Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

5.84
-0.1600-2.67%
Post-market: 5.840.00000.00%16:04 EDT
Volume:35.34K
Turnover:208.58K
Market Cap:2.46M
PE:-0.05
High:6.17
Open:5.89
Low:5.70
Close:6.00
52wk High:3,840.00
52wk Low:5.25
Shares:420.89K
Float Shares:420.71K
Volume Ratio:1.18
T/O Rate:8.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-118.4105
EPS(LYR):-2,427.8177
ROE:-106.98%
ROA:-53.08%
PB:0.19
PE(LYR):0.00

Loading ...

NASDAQ Trade Halt Continues Reason not Available at 03:58 Am

Reuters
·
Oct 05

NASDAQ Trade Halt Continues Halt News Pending at 03:28 Am

Reuters
·
Oct 03

Clearmind Medicine Inc trading halted, news pending

TIPRANKS
·
Oct 03

Clearmind Medicine: Effects 1-for-8 Reverse Share Split, Effective October 5, 2026

THOMSON REUTERS
·
Oct 01

Clearmind Medicine to Consolidate Shares 1-for-8 Oct. 5 on NASDAQ

Reuters
·
Oct 01

NeuroThera Labs Expands U.S. Patent Portfolio in Collaboration with Clearmind Medicine

Reuters
·
Sep 23

Clearmind Medicine Publishes Three US Patent Applications for LSD, Ketamine, Ibogaine Combinations with PEA

Reuters
·
Sep 23

Clearmind Medicine briefs FDA following psychedelic hearing in Washington D.C.

TIPRANKS
·
Sep 17

Clearmind Briefs FDA Panel at Washington Psychedelic Drugs Hearing

Reuters
·
Sep 17

Clearmind Enrolls First AUD Patients in CMND-100 Clinical Trial

Reuters
·
Sep 11

Clearmind Enrolls First Patients with Alcohol Use Disorder in Cmnd-100 Clinical Trial

THOMSON REUTERS
·
Sep 11

Clearmind Net Loss Narrows to USD 907,291 in Q3 FY26; Cash Climbs to USD 12.04 Million at July 31, 2026

Reuters
·
Sep 11

Clearmind Medicine Wins Yale IRB Clearance to Recruit Patients for CMND-100 Trial Parts B and C

Reuters
·
Sep 08

Clearmind Medicine Receives Yale Irb Approval, Enabling Patient Recruitment for Parts B and C of Cmnd-100 Phase I/Ii Trial, Following Positive Safety Results

THOMSON REUTERS
·
Sep 08

Clearmind Medicine Agrees to Buy 51% of Charging Robotics for $2.5 Million

Reuters
·
Sep 04

Clearmind Medicine - to Extend $1.50 Mln Loan to Charging Robotics at 4% Interest

THOMSON REUTERS
·
Sep 04

Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis

THOMSON REUTERS
·
Sep 04

Clearmind Medicine Sets USD 1 Conversion Price for USD 696,079.50 in Notes into Common Shares

Reuters
·
Sep 03

Clearmind Medicine Starts Phase IIa CMND-100 Trial in Alcohol Use Disorder Patients

Reuters
·
Sep 01

Clearmind Reaches Key Milestone: Cmnd-100 Phase Iia NOW Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled

THOMSON REUTERS
·
Sep 01